Company Filing History:
Years Active: 2018-2021
Title: Innovations of Ying Ding in Prostate Cancer Research
Introduction
Ying Ding is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of cancer research. He holds 5 patents that focus on innovative methods and compositions related to prostate cancer. His work aims to improve the understanding and treatment of this prevalent disease.
Latest Patents
One of Ying Ding's latest patents is centered around fusion genes associated with progressive prostate cancer. This invention relates to methods and compositions for determining whether a subject with prostate cancer is at greater risk of developing progressive disease. The research reveals that approximately 90% of men carrying specific fusion genes, such as TRMT11-GRIK2 and SLC45A2-AMACR, experienced severe outcomes like recurrence and metastases after radical prostatectomy. In contrast, only 36% of men without these fusion genes faced similar outcomes. Furthermore, the study indicates that no patient survived five years without recurrence if their primary prostate cancer contained certain fusion genes, highlighting the critical nature of this research.
Career Highlights
Ying Ding is affiliated with the University of Pittsburgh, where he continues to advance his research in cancer genetics. His work has garnered attention for its potential to change the landscape of prostate cancer treatment and patient management.
Collaborations
Ying Ding collaborates with notable colleagues, including Jianhua Luo and Yangping Yu, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative solutions in the fight against cancer.
Conclusion
Ying Ding's contributions to prostate cancer research through his patents and collaborations underscore the importance of innovation in medical science. His work not only aids in understanding the genetic factors of cancer but also paves the way for improved treatment strategies.